Cargando…
Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies
Neutralization of the infectivity of [(3)H]uridine-labeled lactate dehydrogenase-elevating virus (LDV) by polyclonal mouse or rabbit antibodies to the envelope glycoprotein of LDV, VP-3, or by neutralizing monoclonal antibodies (mAb) that recognize a different epitope on VP-3 than the polyclonal ant...
Autores principales: | Plagemann, P. G. W., Harty, J. T., Even, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087216/ https://www.ncbi.nlm.nih.gov/pubmed/1372497 http://dx.doi.org/10.1007/BF01317140 |
Ejemplares similares
-
Lactate dehydrogenase-elevating virus: an ideal persistent virus?
por: Plagemann, Peter G. W., et al.
Publicado: (1995) -
Mouse hepatitis virus infection of mice causes long-term depletion of lactate dehydrogenase-elevating virus-permissive macrophages and T lymphocyte alterations
por: Even, Chen, et al.
Publicado: (1995) -
An ORF-2a protein is not present at a significant level in virions of the arterivirus lactate dehydrogenase-elevating virus
por: Plagemann, Peter G.W.
Publicado: (2001) -
Lactate Dehydrogenase-Elevating Virus, Equine Arteritis Virus, and Simian Hemorrhagic Fever Virus: A New Group of Positive-Strand RNA Viruses
por: Plagemann, Peter G.W., et al.
Publicado: (1992) -
Membrane association of the C-terminal half of the open reading frame 1a protein of lactate dehydrogenase-elevating virus
por: Faaberg, K. S., et al.
Publicado: (1996)